Hypogonadism in Wegener's granulomatosis

References

• Burkhardt O., Köhnlein T., Wrenger E., Lux A., Neumann K. H., Welte T. Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit. Scand J Rheumatol 2007; 36: 119–24
   PubMed Web of Science ®Google Scholar
• de Groot K., Adu D., Savage C. O. The value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical review. Nephrol Dial Transplant 2001; 16: 2018–27
   PubMed Web of Science ®Google Scholar
• Langford C. A., Talar‐Williams C., Sneller M. C. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004; 51: 278–83
   PubMed Web of Science ®Google Scholar
• Metzler C., Fink C., Lamprecht P., Gross W. L., Reinhold‐Keller E. Maintenance of remission with leflunomide in Wegener's granulomatosis. Rheumatology 2004; 43: 315–20
   PubMed Web of Science ®Google Scholar
• Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101–7
   PubMed Web of Science ®Google Scholar
• DeRemee R. A., McDonald T. J., Harrison E. G Jr., Coles D. T. Wegener's granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 1976; 51: 777–81
   PubMed Web of Science ®Google Scholar
• de Groot K., Gross W. L., Herlyn K., Reinhold‐Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001; 55: 31–8
   PubMed Web of Science ®Google Scholar
• Bhasin S., Cunningham G. R., Hayes F. J., Matsumoto A. M., Snyder P. J., Swerdloff R. S., et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006; 91: 1995–2010
   PubMed Web of Science ®Google Scholar
• Reinhold‐Keller E., Herlyn K., Wagner‐Bastmeyer R., Gross W. L. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005; 15;53: 93–9
   Google Scholar
• Haubitz M., Schellong S., Gobel U., Schurek H. J., Schaumann D., Koch K. M. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody‐associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum 1998; 41: 1835–44
   PubMedGoogle Scholar
• Haubitz M., Ehlerding C., Kamino K., Koch K. M., Brunkhorst R. Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases. Clin Nephrol 1998; 49: 19–23
   PubMedGoogle Scholar
• Huong D. L., Amoura Z., Duhaut P., Sbai A., Costedoat N., Wechsler B., et al. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients. J Rheumatol 2002; 29: 2571–6
   PubMed Web of Science ®Google Scholar
• Silva C. A., Brunner H. I. Review: gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 2007; 16: 593–9
   PubMed Web of Science ®Google Scholar
• Martens H. F., Sheets P. K., Tenover J. S., Dugowson C. E., Bremner W. J., Starkebaum G. Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy. J Rheumatol 1994; 21: 1427–31
   PubMed Web of Science ®Google Scholar
• Kamischke A., Kemper D. E., Castel M. A., Luthke M., Rolf C., Behre H. M., et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11: 41–5
   PubMed Web of Science ®Google Scholar
• Watson A. R., Rance C. P., Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J (Clin Res Ed) 1985; 291: 1457–60
   PubMed Web of Science ®Google Scholar
• Stillwell T. J., DeRemee R. A., McDonald T. J., Weiland L. H., Engen D. E. Prostatic involvement in Wegener's granulomatosis. J Urol 1987; 138: 1251–3
   PubMedGoogle Scholar
• Middleton G., Karp D., Lee E., Cush J. Wegener's granulomatosis presenting as lower back pain with prostatitis and ureteral obstruction. J Rheumatol 1994; 21: 566–9
   PubMed Web of Science ®Google Scholar
• Al Arfaj A. Limited Wegener's granulomatosis of the epididymis. Int J Urol 2001; 8: 333–5
   PubMedGoogle Scholar
• Agraharkar M., Gokhale S., Gupta R. Wegener's granulomatosis diagnosed by testicular biopsy. Int Urol Nephrol 2002; 34: 559–64
   PubMedGoogle Scholar
• Brunner A., Tzankov A., Akkad T., Lhotta K., Bartsch G., Mikuz G. Wegener's granulomatosis presenting with gross hematuria due to prostatitis. Virchows Arch 2004; 444: 92–4
   PubMedGoogle Scholar
• Lee S. S., Tang S. H., Sun G. H., Yu C. P., Jin J. S., Chang S. Y. Limited Wegener's granulomatosis of the epididymis and testis. Asian J Androl 2006; 8: 737–9
   PubMedGoogle Scholar
• Huisman T. K., Collins W. T Jr., Voulgarakis G. R. Polyarteritis nodosa masquerading as a primary testicular neoplasm: a case report and review of the literature. J Urol 1990; 144: 1236–8
   PubMedGoogle Scholar
• Lightfoot R. W Jr., Michel B. A., Bloch D. A., Hunder G. G., Zvaifler N. J., McShane D. J. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088–93
   PubMed Web of Science ®Google Scholar
• Halim A., Neild G. H., Levine T., Shaw P. J. Isolated necrotizing granulomatous vasculitis of the epididymis and spermatic cords. World J Urol 1994; 12: 357–8
   PubMedGoogle Scholar
• Ogawa M., Makino N., Hori J., Ueda S., Ohto M., Isaka S. Subclinical ovarian vasculitis developing in a patient with rapidly progressive glomerulonephritis associated with perinuclear antineutrophil cytoplasmic antibody. Nephron 1994; 67: 506–7
   PubMedGoogle Scholar
• Sakai N., Kawamoto K., Fukuoka H., Nakajima S., Kurozumi H. Acute scrotal swelling in Henoch–Schonlein purpura: a case report. Hinyokika Kiyo 2000; 46: 739–41
   PubMedGoogle Scholar
• Dayanir Y. O., Akdilli A., Karaman C. Z., Sonmez F., Karaman G. Epididymoorchitis mimicking testicular torsion in Henoch–Schonlein purpura. Eur Radiol 2001; 11: 2267–9
   PubMedGoogle Scholar
• Eilber K. S., Freedland S. J., Rajfer J. Polyarteritis nodosa presenting as hematuria and a testicular mass. J Urol 2001; 166: 624
   PubMedGoogle Scholar
• Hashiguchi Y., Matsuo Y., Torii Y., Kajiwara T., Kayajima T., Irie K. Polyarteritis nodosa of the epididymis. Abdom Imaging 2001; 26: 102–4
   PubMedGoogle Scholar
• Tanuma Y., Oda T., Yokoo A., Ito S., Takeuchi K. Recurrent polyarteritis nodosa limited to the testis. J Urol 2003; 170: 1953
   PubMed Web of Science ®Google Scholar
• Leavitt R. Y., Fauci A. S., Bloch D. A., Michel B. A., Hunder G. G., Arend W. P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101–7
   PubMed Web of Science ®Google Scholar
• Kalyani R. R., Gavini S., Dobs A. S. Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 2007; 36: 333–48
   PubMed Web of Science ®Google Scholar
• Olszynski W. P., Shawn Davison K., Adachi J. D., Brown J. P., Cummings S. R., Hanley D. A., et al. Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 2004; 26: 15–28
   PubMed Web of Science ®Google Scholar
• Guillevin L., Pagnoux C. Therapeutic strategies for systemic necrotizing vasculitides. Allergol Int 2007; 56: 105–11
   PubMedGoogle Scholar
• Nelson L. M., Anasti J. N., Kimzey L. M., Defensor R. A., Lipetz K. J., White B. J. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79: 1470–5
   PubMed Web of Science ®Google Scholar